Correlations of serum uric acid level with non-alcoholic fatty liver disease and carotid atherosclerosis in young and middle-aged people

XU Qi; ZHAO Donghui; ZHANG Lingling; WANG Xu; WANG Tairong

doi:10.7619/jcmp.20220338

Journal of Clinical Medicine in Practice > 2022 > 26(10): 20-25. > DOI: 10.7619/jcmp.20220338

XU Qi, ZHAO Donghui, ZHANG Lingling, WANG Xu, WANG Tairong. Correlations of serum uric acid level with non-alcoholic fatty liver disease and carotid atherosclerosis in young and middle-aged people[J]. Journal of Clinical Medicine in Practice, 2022, 26(10): 20-25. DOI: 10.7619/jcmp.20220338

Citation:

PDF (729 KB)

Correlations of serum uric acid level with non-alcoholic fatty liver disease and carotid atherosclerosis in young and middle-aged people

1.
Department of Health Management, the First People's Hospital Affiliated to Medical College of Shanghai Jiaotong University, Shanghai, 200080
2.
Shanghai Bureau of Statistics, Shanghai, 200041
3.
Department of Pathology of School of Basic Medicine of Medical College of Shanghai Jiaotong University, Shanghai, 200025
4.
Department of Health Management, Luwan Branch of Ruijin Hospital Affiliated to Medical College of Shanghai Jiaotong University, Shanghai, 200020

More Information

Received Date: January 26, 2022
Available Online: April 19, 2022

Graphical Abstract

Abstract

Abstract

Objective
To explore the correlations of serum uric acid (SUA) level with non-alcoholic fatty liver disease (NAFLD) and carotid atherosclerosis (CAS) in young and middle-aged people with different genders in physical examination.
Methods
A total of 1 274 incumbent employees with physical examination from March to June 2021 were selected as research objects.The SUA levels and the detection rates of hyperuricemia (HUA) in young and middle-aged people with different gender and age were observed; the correlations of SUA level with blood glucose and blood lipid level were analyzed; according to the quartile of SUA level, the correlations of different SUA levels with elevated blood glucose, abnormal fat metabolism, NAFLD and CAS were analyzed.
Results
Except for age group of 60 to 64 years, the SUA levels of men in other age groups were significantly higher than those of women (P < 0.01);the detection rates of HUA in men in other age groups were higher than those in women, and the significant differences were observed between men and women in the age groups of ≤40 years and 41 to 49 years (P < 0.01);the SUA levels in young and middle-aged men showed decreasing trend with age growing, while that of women increased.SUA level was positively correlated with fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C)(r=0.113, 0.092, 0.130, 0.431, 0.202, P≤0.001), and negatively correlated with high density lipoprotein cholesterol (HDL-C)(r=-0.365, P < 0.001).Further grouping was conducted according to the quartile of SUA level.With the increase of SUA level, TC, TG, HDL-C and LDL-C gradually tended to be abnormal, the difference between the fourth quartile (Q₄ group) and the first quartile (Q₁ group) was statistically significant (P < 0.05).Multivariate Logistic regression analysis showed that the risk of abnormal lipid metabolism, NAFLD and CAS increased significantly with the increase of SUA level; after adjusting for other factors, taking group Q₁ as the reference group, the risk of abnormal lipid metabolism and NAFLD in male Q₄ group increased by 221.5%(OR=3.215, 95%CI, 2.154 to 4.798) and 216.3%(OR=3.163, 95%CI, 1.999 to 5.005) respectively, and the risk of CAS in male Q₃ group increased by 87.9%(OR=1.879, 95%CI, 1.031 to 3.426);the risk of abnormal lipid metabolism in female Q₄ group increased by 169.8%(OR=2.698, 95%CI, 1.105 to 6.587).
Conclusion
Different SUA levels in middle-aged and young people are significantly correlated with FBG, abnormal lipid metabolism, NAFLD and the prevalence of CAS.The risk of men is significantly higher than that of women.
- middle-aged and young people,
- serum uric acid,
- non-alcoholic fatty liver disease,
- carotid atherosclerosis,
- correlation,
- gender

FullText(HTML)

References (23)

References

[1]	WANG J H, MA L, CHEN S H, et al. Risk for the development of non-alcoholic fatty liver disease: a prospective study[J]. J Gastroenterol Hepatol, 2018, 33(8): 1518-1523. doi: 10.1111/jgh.14105
[2]	邵幼林, 范建高. 非酒精性脂肪性肝病的流行现状与危害[J]. 中华肝脏病杂志, 2019, 27(1): 10-13. doi: 10.3760/cma.j.issn.1007-3418.2019.01.004
[3]	施佳成, 黄倩, 沈艳明, 等. 不同血清尿酸水平与心血管疾病危险因素的相关性研究[J]. 江西医药, 2020, 55(8): 984-988. doi: 10.3969/j.issn.1006-2238.2020.08.006
[4]	任贝贝, 方琨, 王雪春, 等. 血尿酸与中年男性颈动脉粥样硬化的关系研究[J]. 实用心脑肺血管病杂志, 2020, 28(10): 62-65. doi: 10.3969/j.issn.1008-5971.2020.10.011
[5]	高尿酸血症相关疾病诊疗多学科共识专家组. 中国高尿酸血症相关疾病诊疗多学科专家共识[J]. 中华内科杂志, 2017, 56(3): 235-248. doi: 10.3760/cma.j.issn.0578-1426.2017.03.021
[6]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ202106003.htm
[7]	诸骏仁, 高润霖, 赵水平, 等. 中国成人血脂异常防治指南(2016年修订版)[J]. 中国循环杂志, 2016, 31(10): 937-953. doi: 10.3969/j.issn.1000-3614.2016.10.001
[8]	中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 现代医药卫生, 2011, 27(5): 641-644. https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY201207005.htm
[9]	李胜利. 对中国医师协会超声医师分会《产前超声检查指南(2012)》的深入解读[J]. 中华医学超声杂志: 电子版, 2014, 11(4): 266-282. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHCD201404001.htm
[10]	周薇, 单年春, 谭英, 等. 医务工作者高脂血症与高尿酸血症关系的纵向研究[J]. 中华健康管理学杂志, 2018, 4(3): 252-258. doi: 10.3760/cma.j.issn.1674-0815.2018.03.011
[11]	蒋明凤, 普娅坤, 巴雪娇, 等. 不同性别青年人尿酸水平与体质量指数的相关性研究[J]. 检验医学与临床, 2021, 18(3): 336-339. doi: 10.3969/j.issn.1672-9455.2021.03.013
[12]	李剑, 卢艳慧, 邵迎红, 等. 老年人群血尿酸水平与代谢综合征各组分的研究[J]. 中华老年心脑血管病杂志, 2008, 10(6): 425-427. doi: 10.3969/j.issn.1009-0126.2008.06.009
[13]	王尊, 陈东宁, 崔晶, 等. 正常体质指数人群血尿酸水平与非酒精性脂肪性肝病相关性的研究[J]. 中华健康管理学杂志, 2016, 10(6): 445-449. doi: 10.3760/cma.j.issn.1674-0815.2016.06.007
[14]	王丽莹, 李强. 血尿酸与非酒精性脂肪肝的相关性研究进展[J]. 中国全科医学, 2018, 21(27): 3397-3402. doi: 10.3969/j.issn.1007-9572.2018.00.232
[15]	XIE D, ZHAO H R, LU J M, et al. High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling[J]. Am J Physiol Endocrinol Metab, 2021, 320(6): E1032-E1043. doi: 10.1152/ajpendo.00518.2020
[16]	YU W, CHENG J D. Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective[J]. Front Pharmacol, 2020, 11: 582680. doi: 10.3389/fphar.2020.582680
[17]	FEIG D I, KANG D H, JOHNSON R J. Uric acid and cardiovascular risk[J]. N Engl J Med, 2008, 359(17): 1811-1821. doi: 10.1056/NEJMra0800885
[18]	范存芳, 徐永庆. 高尿酸血症对非酒精性脂肪肝患者血管内皮功能及颈动脉粥样硬化的影响[J]. 中国中西医结合影像学杂志, 2019, 17(5): 470-473. doi: 10.3969/j.issn.1672-0512.2019.05.009
[19]	KOPEL E. Serum uric acid and cardiovascular risk: an early wake-up call[J]. J Adolesc Health, 2015, 56(4): 363-364. doi: 10.1016/j.jadohealth.2015.01.014
[20]	CHALASANI N, YOUNOSSI Z, LAVINE J E, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 67(1): 328-357. doi: 10.1002/hep.29367
[21]	王洪莎, 郭蔚莹. 高尿酸血症与高血糖、高血压及肥胖的关系[J]. 中国老年学杂志, 2016, 36(22): 5729-5732. doi: 10.3969/j.issn.1005-9202.2016.22.112
[22]	WARDHANA W, RUDIJANTO A. Effect of uric acid on blood glucose levels[J]. Acta Med Indones, 2018, 50(3): 253-256.
[23]	周启蒙, 赵晓悦, 孔德文, 等. 桑色素对高尿酸血症模型小鼠肝肾功能及血糖和血脂水平的影响及其机制[J]. 中国药理学与毒理学杂志, 2021, 35(8): 595-601. doi: 10.3867/j.issn.1000-3002.2021.08.005

[1]	YANG Xueqing, DU Yong, CHEN Yahong, WU Jie. A scoping review in the application of regional citrate anticoagulation in patients undergoing continuous renal replacement therapy[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 142-148. DOI: 10.7619/jcmp.20242279
[2]	ZHAO Sijia, HU Yaoyao, ZHU Ye, LIU Jia. Effect of dabigatran etexilate in elderly patients with non-valvular atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 29-33, 38. DOI: 10.7619/jcmp.20232751
[3]	HU Wenqi, ZHANG Xiaochun, YE Mao. Research progress on compliance of anticoagulation therapy in patients with major orthopedic surgery[J]. Journal of Clinical Medicine in Practice, 2023, 27(12): 131-135. DOI: 10.7619/jcmp.20230670
[4]	CHEN Hongbo, WANG Yuanyuan, LI Jing, CAO Yabing, LI Zhengchuan. Clinical characteristics and etiology analysis of nonvariceal upper gastrointestinal bleeding in the treatment of different antithrombotic drugs[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 81-85. DOI: 10.7619/jcmp.20223326
[5]	XU Lele, DING Qi, CHEN Ya'ou. Effect of low molecular weight heparin anticoagulation on blood calcium in patients with severe pancreatitis[J]. Journal of Clinical Medicine in Practice, 2020, 24(23): 96-98. DOI: 10.7619/jcmp.202023029
[6]	PENG Li, GAN Qin, WU Ying, PAN Lishou, XIAO Rong, DING Dan. Clinical effect of Xuefu Zhuyu Decoction in treating sleep disorder patients with ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2020, 24(21): 46-49. DOI: 10.7619/jcmp.202021014
[7]	ZHUO Rui, LI Jiehua. Exploration on anticoagulant therapy in elderly patients with non-valvular atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 42-44. DOI: 10.7619/jcmp.202012012
[8]	HUANG Meimei, KANG Yun, LIU Li, DONG Qin. Application of thrombelastogram in nursing and anticoagulant therapy for patients with heart valve replacement[J]. Journal of Clinical Medicine in Practice, 2017, (12): 49-52. DOI: 10.7619/jcmp.201712015
[9]	WANG Chengtai. Clinical efficacy of qi-tonifying and stasis-eliminating therapy in treatment of ischemic stroke patients in recovery period and its influence on levels of hs-CRP, Fg and HCY[J]. Journal of Clinical Medicine in Practice, 2016, (3): 28-31. DOI: 10.7619/jcmp.201603009
[10]	TAO Yuan, SUN Guo-zhen, TIAN Jin-ping, YANG Bing, CHEN Hong-wu. The nursing and observation of the atrial fibrillation patients with anticoagulation therapy[J]. Journal of Clinical Medicine in Practice, 2011, (2): 11-13. DOI: 10.3969/j.issn.1672-2353.2011.02.006

Cited By

Get Citation

PDF

XML

Article views (282) PDF downloads (19)

Turn off MathJax

Article Contents

Abstract

References

Correlations of serum uric acid level with non-alcoholic fatty liver disease and carotid atherosclerosis in young and middle-aged people

Abstract

References

Related Articles

Catalog

Correlations of serum uric acid level with non-alcoholic fatty liver disease and carotid atherosclerosis in young and middle-aged people

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content